lunedì, 4 maggio 2026

Notizie Newsletter

CAR T-Cell Therapy Coverage Decision Improves Medicare Beneficiary Access to Cancer Care

Aug 8, 2019 - “ASCO applauds the Centers for Medicare & Medicaid Services (CMS) for releasing a national coverage determination (NCD) on CAR T-cell therapy that provides increased access to an innovative cancer treatment to Medicare beneficiaries nationwide. The ...
Leggi tutto

USPSTF Recommendation on Screening for Pancreatic Cancer in Asymptomatic Adults

Aug 13, 2019 - As reported in JAMA, the U.S. Preventive Services Task Force (USPSTF), in a reaffirmation of its 2004 recommendation, has recommended against screening for pancreatic cancer in asymptomatic adults (a grade D recommendation). In developing the current recommendation, ...
Leggi tutto

NCORP Expands to More Sites

Aug 20, 2019 - The National Cancer Institute (NCI) has awarded 53 grants to researchers in the NCI Community Oncology Research Program (NCORP) to conduct multisite cancer clinical trials and cancer care delivery studies in their communities. In addition to seven research ...
Leggi tutto

FDA Approves Darolutamide for Nonmetastatic CRPC

July 31, 2019 - The FDA has approved darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer. The approval of the androgen receptor inhibitor is based on data from the phase III ARAMIS trial, in which darolutamide in combination ...
Leggi tutto

Supporting medicine developers in generating quality data packages in early access approaches (PRIME and breakthrough therapies): workshop report published

July 31, 2019 - EMA and the US Food and Drug Administration (FDA) have published today a report on their joint workshop with stakeholders held on 26 November 2018. The aim of this workshop was to discuss scientific and regulatory approaches to address quality and manufacturing ...
Leggi tutto

30 luglio 2019 – AIFA pubblica Rapporto Vaccini 2018

1 agosto 2019 – Aggiornamento modulistica autorizzazione sperimentazioni cliniche ed emendamenti sostanziali

1 agosto 2019 – Access program Olaratumab (Eli Lilly)

7 agosto 2019 – Consultazione dei dati pubblicati nel Rapporto nazionale sull’uso dei farmaci in Italia – anno 2018

7 agosto 2019 – AIFA approva la rimborsabilità della prima terapia CAR-T